QC Trials (Site 1117), 300 W. 41st Street, Ste. 203 — Miami Beach, Florida

QC Trials (Site 1117), 300 W. 41st Street, Ste. 203 is a clinical research site located in Miami Beach, Florida, United States 33140-3627.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

QC Trials (Site 1117), 300 W. 41st Street, Ste. 203 has participated in 1 clinical trials.

Therapeutic areas: Coronavirus, Covid19.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for QC Trials (Site 1117), 300 W. 41st Street, Ste. 203?

QC Trials (Site 1117), 300 W. 41st Street, Ste. 203 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has QC Trials (Site 1117), 300 W. 41st Street, Ste. 203 conducted?

QC Trials (Site 1117), 300 W. 41st Street, Ste. 203 has 1 clinical trials on record. Their work covers Coronavirus, Covid19.

Is QC Trials (Site 1117), 300 W. 41st Street, Ste. 203 accredited by Crixeo Health?

QC Trials (Site 1117), 300 W. 41st Street, Ste. 203 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about QC Trials (Site 1117), 300 W. 41st Street, Ste. 203?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.